Gain granted $2.8M to develop lead therapy for GBA1 Parkinson’s
Gain Therapeutics has been awarded about $2.8 million to advance the development of GT-02287, its lead therapeutic candidate for…
Articles by Lindsey Shapiro, PhD
NeuroOne Evo sEEG electrode device available commercially in US
NeuroOne Medical Technologies‘ Evo stereoelectroencephalography (sEEG) electrodes for measuring or stimulating brain activity in people with neurological diseases like…
NeuroSense to target AGO2 protein as potential Parkinson’s therapy
People newly diagnosed with Parkinson’s disease were found to have significantly lower blood levels of the argonaute 2 (AGO2)…
AAN 2023: IPX203 still safe, effective in extension study
IPX203, Amneal Pharmaceuticals‘ investigational extended-release carbidopa/levodopa (CD/LD) treatment for Parkinson’s disease, continued to exhibit a favorable safety and…
AAN 2023: Fewer motor symptoms found with prasinezumab for 3 years
Parkinson’s disease patients treated with prasinezumab for three years — as part of a long-term extension of the Phase…
Exercise, especially mind-body, eases motor symptoms
Physiotherapy, and mind-body exercise particularly, can meaningfully ease motor symptoms of Parkinson’s disease, a recent meta-analysis of clinical trial…
Anti-nausea meds not necessary when starting Kynmobi
Medications to prevent nausea and vomiting usually are not necessary for Parkinson’s disease patients beginning treatment with Kynmobi…
Parkinson’s speech issues linked to activity changes in brain region
Changes in the electrical activity of a brain region called the left inferior frontal cortex (LIFC) may underlie certain speech…
Allantoin may hold promise as prognostic biomarker in Parkinson’s
A molecule associated with oxidative stress, called allantoin, is found at higher levels in the blood of people with…
Nonwhite Parkinson’s patients see worse HRQoL than white patients
Black, Hispanic, and Asian people with Parkinson’s disease report lower health-related quality of life (HRQoL) than their white counterparts,…